Kensey Nash withdraws FY2012 guidance on St Jude Angio-Seal royalty row

This article was originally published in Clinica

20 Dec 2011
News

Madeleine Armstrong madeleine.armstrong@informa.com

Executive Summary

Kensey Nash has withdrawn its financial guidance for the rest of fiscal year 2012 as it seeks to resolve a dispute with St Jude Medical over royalty fees for the Angio-Seal vascular closure device.

Already Registered? Sign in to continue reading.

New to Medtech Insight? Start a free trial today!

Table
View full table

Topics

Industries
Medical Device

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Medical Device

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

MT098319

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

MT098319

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Kensey Nash withdraws FY2012 guidance on St Jude Angio-Seal royalty row

News

Executive Summary

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert